NCT00870779View on ClinicalTrials.gov

Fluorescence Guided Resection of Brain Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 2, 2012

Study Completion Date

July 2, 2013

Conditions
Brain Tumors
Interventions
DRUG

5-aminolevulinic acid

20mg/kg 3 hours prior to surgery

Trial Locations (1)

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

David W. Roberts

OTHER

NCT00870779 - Fluorescence Guided Resection of Brain Tumors | Biotech Hunter | Biotech Hunter